🧬 The Biotech Startups Podcast, brought to you by Excedr—empowering life science startups with founder-friendly equipment leasing to fast-track R&D and drive commercialization success.
🔬 Know someone in need of lab equipment? Join Excedr’s referral program: Give your friends $1,000 and earn $1,000 for every qualified referral! 💸
🔗 Get your unique referral link here: refer.excedr.com/ZTHETY. 
Part 4 of 4: In this episode, Jon Chee hosts Kate Neville, PhD, Partner at Marshall Gerstein—a law firm with over 60 years of expertise in delivering sophisticated intellectual property advice and legal services to leading businesses, research institutions, universities, and entrepreneurs worldwide.
Kate is an accomplished attorney with a doctoral background in microbiology and immunology who specializes in global patent prosecution and strategic management. She has over a decade of experience, and works with a wide range of clients, from biotech startups to big pharma to non-profits. 
Kate has been recognized as a "World's Leading Patent Practitioner" by IAM magazine since 2013, an Illinois Super Lawyer since 2018, and is included in The Best Lawyers in America© for Patent Law.
In this episode, you’ll hear about:

• Why securing a patent is only the first step in IP protection
• Weighing litigation versus licensing to safeguard your IP
• Leveraging technology transfer and academic collaborations for innovation
• Driving innovation through incremental advancements in your IP portfolio
• Kate’s journey from scientist to partner, with insightful advice for those navigating career transitions

If you enjoy The Biotech Startups Podcast, please consider subscribing, leaving a review, or sharing it with your friends. Thanks for listening!
Subscribe to the podcast: https://podcasts.apple.com/us/podcast/the-biotech-startups-podcast/id1679591994
Find Our Guest, Kate Neville, at these links: https://www.linkedin.com/in/kate-neville-phd/ https://www.marshallip.com/ 
Find Our Host, Jon Chee, at these links: https://www.linkedin.com/in/joncheehttps://www.excedr.com
Excedr Socials & WebsiteLinkedIn: https://www.linkedin.com/company/excedr/ Youtube: https://www.youtube.com/@excedr Instagram: https://www.instagram.com/excedr_inc Twitter: https://twitter.com/ExcedrInc Facebook: https://www.facebook.com/excedr TikTok: https://www.tiktok.com/@excedr Podcast Website: https://www.thebiotechstartupspodcast.com/ 
Enriched Notes:

Topics Mentioned:Marshall Gerstein: https://www.marshallip.com/IP Enforcement Strategies: https://www.wipo.int/en/web/ip-enforcement/IP Strategies for Biotechs: https://www.excedr.com/resources/intellectual-property-strategy-for-biotechsIP Rights to Understand: https://www.excedr.com/resources/intellectual-property-rights-for-biotechsIntellectual Property 101: https://www.excedr.com/resources/intellectual-property-guideTech Transfer 101: https://www.excedr.com/blog/what-is-tech-transferPatent Licensing 101: https://www.excedr.com/resources/how-patent-licensing-worksGuide to Life Sciences Licensing: https://www.excedr.com/blog/life-sciences-licensing-agreements-guideBiotech Startup Support: https://www.excedr.com/resources-category/biotech-startup-support
Timestamps:00:00 Intro02:04 The challenges of enforcing IP protections03:46 Balancing litigation and licensing as a business decision07:13 Technology transfer breakdown and how to secure your next big idea09:07 Exploring shelved pharma compounds as IP opportunities11:29 Avoiding common IP pitfalls for biotech startups14:10 The value of fresh perspectives in biotech entrepreneurship16:35 Challenges of transitioning from the bench to law practice20:52 Insights into life as a partner in an IP law firm23:09 2-year vision at Marshall Gerstein26:42 Closing questions and advice for biotech founders29:47 OutroThe Biotech Startups Podcast gives you a front-row seat to the business and science of building a biotech. Hosted by Jon Chee, CEO of Excedr, the show features honest conversations with founders, execs, and investors about their work, their companies, and how they got there. From scientific breakthroughs to startup lessons, each episode explores what it really takes to grow a life science company—from pre-seed to IPO.